Jafco Super V3 Investment Limited Partnership - Net Worth and Insider Trading
Jafco Super V3 Investment Limited Partnership Net Worth
The estimated net worth of Jafco Super V3 Investment Limited Partnership is at least $1,553 dollars as of 2024-09-20. Jafco Super V3 Investment Limited Partnership is the 10% Owner of TRACON Pharmaceuticals Inc and owns about 7,485 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $1,553. Details can be seen in Jafco Super V3 Investment Limited Partnership's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jafco Super V3 Investment Limited Partnership has not made any transactions after 2015-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jafco Super V3 Investment Limited Partnership
Jafco Super V3 Investment Limited Partnership Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jafco Super V3 Investment Limited Partnership owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , Sesen Bio Inc (SESN) , and CARISMA Therapeutics Inc (CARM) .
Insider Ownership Summary of Jafco Super V3 Investment Limited Partnership
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2015-10-16 | 10 percent owner |
| SESN | Sesen Bio Inc | 2014-02-05 | 10 percent owner |
| CARM | CARISMA Therapeutics Inc | 2014-02-05 | 10 percent owner |
Jafco Super V3 Investment Limited Partnership Latest Holdings Summary
Jafco Super V3 Investment Limited Partnership currently owns a total of 1 stock. Jafco Super V3 Investment Limited Partnership owns 7,485 shares of TRACON Pharmaceuticals Inc (TCON) as of October 16, 2015, with a value of $1,553.
Latest Holdings of Jafco Super V3 Investment Limited Partnership
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2015-10-16 | 7,485 | 0.21 | 1,553 |
Holding Weightings of Jafco Super V3 Investment Limited Partnership
Jafco Super V3 Investment Limited Partnership Form 4 Trading Tracker
According to the SEC Form 4 filings, Jafco Super V3 Investment Limited Partnership has made a total of 0 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years. The most-recent trade in TRACON Pharmaceuticals Inc is the sale of 7 shares on October 16, 2015, which brought Jafco Super V3 Investment Limited Partnership around $14,850.
Insider Trading History of Jafco Super V3 Investment Limited Partnership
- 1
Jafco Super V3 Investment Limited Partnership Trading Performance
Jafco Super V3 Investment Limited Partnership Ownership Network
Jafco Super V3 Investment Limited Partnership Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Jafco Super V3 Investment Limited Partnership is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Jafco Super V3 Investment Limited Partnership made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. , and a net purchase of 50,999 shares made by Charles Theuer .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 2,550 shares were bought by its insiders, resulting in a net sale of 235,650 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Jafco Super V3 Investment Limited Partnership Mailing Address
Above is the net worth, insider trading, and ownership report for Jafco Super V3 Investment Limited Partnership. You might contact Jafco Super V3 Investment Limited Partnership via mailing address: Otemachi First Square, West Tower 11f, 1-5-1 Otemachi, Chiyoda-ku, Tokyo 100-0004 M0 100-0004.
Discussions on Jafco Super V3 Investment Limited Partnership
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
